Healthcare -
Biotechnology - NASDAQ - US
$ 6.37
-2.9 %
$ 438 M
Market Cap
-2.3
P/E
ARVN - REVENUE
Revenue ARVN - Arvinas, Inc.
263 M
LAST VALUE
41.58%
2 YEAR CAGR
43.71%
5 YEAR CAGR
0.00%
10 YEAR CAGR